Lung Therapeutics Inc. 13D and 13G filings for TFF Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 3:32 pm Sale |
2022-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
Lung Therapeutics Inc. | 30,920 2.100% |
-58,480 (-65.41%) |
Filing |
| 2022-02-14 3:07 pm Sale |
2021-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
Lung Therapeutics Inc. | 89,400 8.810% |
-28,600 (-24.24%) |
Filing |
| 2021-02-03 3:10 pm Sale |
2020-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
Lung Therapeutics Inc. | 118,000 13.300% |
-42,000 (-26.25%) |
Filing |